Thus, in 11/13 patients with a low SF3B1 VAF either deletions on chromosome 5 (n = 5), additional spliceosome (n = 4) or TP53 mutations (n = 2) were identified at MDS diagnosis. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.